All posts tagged
chronic obstructive pulmonary disease
UPDATE: Verona sets terms & dials back its IPO goal to a still-hefty €75M
Can this British Biotech Overcome Failure buying drugs from AstraZeneca?
UK Partnership is looking for new Epigenetic targets in Respiratory Disease
Novartis completed two successful Phase III to smooth FDA’s approval
Labiotech UG, All Rights Reserved -
Send this to friend